Janus Henderson Group’s ChemoCentryx, Inc. CCXI Stock Holding History

Janus Henderson Group’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-265,478	Closed	-$13.7M	–	2648
2022 Q3	$13.7M	Buy	265,478 +255,524	+2,567%	+$10.6M	0.01%	765
2022 Q2	$246K	Buy	9,954 +57	+0.6%	+$1.26K	﹤0.01%	2204
2022 Q1	$248K	Buy	9,897 +1	+0%	+$28	﹤0.01%	2334
2021 Q4	$361K	Buy	+9,896	New	+$347K	﹤0.01%	2103

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Janus Henderson Group's CCXI Position: Q4 2022 in Review

Janus Henderson Group sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 265,478 shares — an estimated $13.7M sold.

Janus Henderson Group first reported a position in CCXI in Q4 2021 and held it in 4 quarters. The position peaked at $13.7M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Janus Henderson Group reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Janus Henderson Group sold 265,478 ChemoCentryx, Inc. shares in Q4 2022, an estimated $13.7M.
Janus Henderson Group first reported a position in ChemoCentryx, Inc. in Q4 2021 and held it in 4 quarters.
Janus Henderson Group's ChemoCentryx, Inc. position peaked at $13.7M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.